Creatine Emerges as Mitochondrial Medicine Tool for Personalized Health
Review positions creatine beyond sports nutrition as a diagnostic biomarker and therapeutic agent for mitochondrial dysfunction in aging and disease.
Summary
This comprehensive review repositions creatine from a sports supplement to a clinical tool for mitochondrial medicine. The authors highlight creatine's roles in stabilizing mitochondrial membranes, reducing oxidative stress, and supporting energy production. They propose using creatine levels as biomarkers for early disease detection and developing personalized supplementation strategies. The review addresses current gaps in standardized testing, predictive modeling, and individualized dosing that limit clinical translation.
Detailed Summary
Creatine is gaining recognition as a mitochondrial theranostic agent with significant potential for predictive, preventive, and personalized medicine (PPPM). Beyond its traditional role in muscle energy metabolism, creatine demonstrates multiple protective effects on mitochondria including membrane stabilization, oxidative stress reduction, and support of mitochondrial biogenesis.
This mini-review synthesizes evidence showing creatine's multifaceted biological functions across physiological and pathological states. The authors highlight how creatine sustains ATP homeostasis through the creatine kinase-phosphocreatine system while influencing mitochondrial dynamics and redox balance. These effects make it valuable for diseases characterized by impaired bioenergetics, including neurodegenerative conditions, metabolic disorders, and age-related pathologies.
The review identifies four critical gaps limiting clinical translation: lack of standardized biomarkers for early bioenergetic deficits, limited incorporation into predictive risk models, insufficient personalization despite known individual variability, and underdeveloped clinical validation of advanced formulations. The authors propose creatine profiling through biofluids, tissue sampling, and magnetic resonance spectroscopy as minimally invasive approaches for early detection and patient stratification.
A clinical illustration demonstrates creatine's diagnostic potential in long COVID patients, where muscle and brain creatine levels measured by MRS revealed bioenergetic deficits not detected by standard tests. The authors envision personalized intervention strategies guided by molecular profiling to maximize efficacy while minimizing risk.
Integration with multi-omics data, computational modeling, and digital health monitoring could overcome existing barriers. By reframing creatine as a scalable, safe, and cost-effective component of mitochondrial medicine, this approach could support proactive health maintenance and disease prevention.
Key Findings
- Creatine stabilizes mitochondrial membranes and reduces oxidative stress beyond energy metabolism
- Tissue creatine levels serve as biomarkers for mitochondrial dysfunction in multiple diseases
- Magnetic resonance spectroscopy enables non-invasive creatine profiling in muscle and brain
- Long COVID patients showed reduced creatine levels correlating with persistent fatigue symptoms
- Personalized supplementation strategies could optimize therapeutic outcomes
Methodology
This is a comprehensive mini-review synthesizing existing literature on creatine's mitochondrial effects. The authors present a clinical case series of 19 long COVID patients using proton magnetic resonance spectroscopy to measure tissue creatine levels.
Study Limitations
This is a review paper rather than original research, and the clinical illustration involves a small case series. The proposed diagnostic and therapeutic applications require validation in larger clinical trials before widespread implementation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
